Goodrx Holdings Inc Cl A (GDRX) Stock Price, Quote & News

Company Profile

GoodRx Holdings, Inc., together with its subsidiaries, offers information and tools that enable consumers to compare prices and save on their prescription drug purchases in the United States. The company operates a price comparison platform that provides consumers with curated, geographically relevant prescription pricing, and access to negotiated prices. It also offers other healthcare products and services, including subscription programs and pharma manufacturer solutions, as well as telehealt...

Industry: Health Information Services

Sector: Healthcare

Phone: 855 268 2822

Website: www.goodrx.com

Address:

2701 Olympic Boulevard, Santa Monica, United States

Hihosilveraway11 Mar. 16 at 3:42 AM

$GDRX can we get out of the 2s already!

0 · Reply

Yayomamon Mar. 15 at 6:27 AM

$GDRX okay everyone be honest what’s our price target for this year bc it’s not looking so great rn unfortunately

1 · Reply

WallStreetBuyDip Mar. 15 at 4:54 AM

$GDRX trading at $2 with volume 52% below average, while $CVS priced at $76 with volume 46% below average. Both in PharmaRetail sector, but CVS showing more stability with a higher price point. Will sector trends boost GDRX's volume soon?

0 · Reply

NowWeKnow Mar. 15 at 2:33 AM

$GDRX Orange 🍊 turd will kill all momentum

0 · Reply

JPC30 Mar. 14 at 6:25 PM

$GDRX will do great in time. current holdings 15,000 shares. aim to have around $30,000 if price continues to chop between here n lows

0 · Reply

Yayomamon Mar. 14 at 5:18 AM

$GDRX 5$ please god

0 · Reply

Plumbcrazy1017 Mar. 14 at 1:40 AM

$GDRX it’s going to go up

0 · Reply

PivotalSaints Mar. 13 at 9:59 PM

$BITF $GDRX $SOL.X $SPY Hilarious

0 · Reply

PivotalSaints Mar. 13 at 7:41 PM

$BITF $GDRX $SOL.X $SPY Now what? You’ve answered incorrectly every time so where do we go? Up

0 · Reply

fishinNbanjo Mar. 13 at 7:41 PM

$GDRX it's never going up

0 · Reply

GoodRx Partners with Viatris to Offer Up to 85% Savings on Established Brand Medications

Mar 6, 2026, 9:00 AM EST - 9 days ago

GoodRx to Expand Employer-Sponsored Access to Zepbound® KwikPen®

Feb 26, 2026, 3:17 PM EST - 17 days ago

GoodRx Holdings, Inc. (GDRX) Q4 2025 Earnings Call Transcript

Feb 26, 2026, 11:40 AM EST - 17 days ago

GoodRx Targets Digital Subscription Growth Amid 14% Dip in Active Consumers

Feb 25, 2026, 4:05 PM EST - 18 days ago

GoodRx Reports Fourth Quarter and Full Year 2025 Results

Feb 24, 2026, 9:00 AM EST - 19 days ago

GoodRx Expands Into Employer Market With Launch of “GoodRx Employer Direct”

Feb 5, 2026, 7:44 PM EST - 5 weeks ago

GoodRx Powers Pricing for Leading Brand Medications on TrumpRx

Feb 2, 2026, 9:00 AM EST - 5 weeks ago

GoodRx Earns HITRUST i1 Certification for the Second Consecutive Year, Reinforcing Its Commitment to Protecting Healthcare Data at Scale

Jan 28, 2026, 4:05 PM EST - 6 weeks ago

GoodRx Announces Date for Fourth Quarter and Full Year 2025 Earnings Release and Conference Call

Jan 13, 2026, 7:55 PM EST - 2 months ago

GoodRx Holdings, Inc. (GDRX) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

Jan 13, 2026, 8:00 AM EST - 2 months ago

Surescripts and GoodRx Partner to Advance Patient Price Transparency

Jan 8, 2026, 9:00 AM EST - 2 months ago

GoodRx Launches RxSmartSaver at Giant Eagle Pharmacies

Jan 5, 2026, 8:05 AM EST - 2 months ago

GoodRx Now Offers Novo Nordisk's Cash Price for the Launch of the Wegovy® Pill

Dec 16, 2025, 4:05 PM EST - 3 months ago

GoodRx to Participate in the 44th Annual J.P. Morgan Healthcare Conference

Nov 17, 2025, 8:35 AM EST - 4 months ago

GoodRx Launches New $39 Per Month Weight Loss Telemedicine Subscription, Unveils Industry-Leading Introductory Cash Price of $199 Per Month for Ozempic® and Wegovy®

Nov 5, 2025, 2:31 PM EST - 4 months ago

GoodRx Holdings, Inc. (GDRX) Q3 2025 Earnings Call Transcript

Nov 5, 2025, 1:46 PM EST - 4 months ago

GoodRx Sees ‘Profund Transformation' in Prescriptions With TrumpRx

Nov 4, 2025, 4:05 PM EST - 4 months ago

GoodRx Reports Third Quarter 2025 Results

Nov 4, 2025, 9:55 AM EST - 4 months ago

Should You Buy GoodRx Stock?

Oct 15, 2025, 9:00 AM EDT - 5 months ago

GoodRx Launches New Hair Loss Subscription for Men to Simplify Access to Affordable Treatment

Oct 10, 2025, 3:20 PM EDT - 5 months ago

GoodRx: Novo Deal And TrumpRx Talks Point To Ebitda/FCF Upside

Oct 9, 2025, 3:09 PM EDT - 5 months ago

Trump Administration Engages Pharmacies, GoodRx For TrumpRx Launch

Oct 9, 2025, 12:27 PM EDT - 5 months ago

Exclusive: US pharmacies, drug discounters are discussing TrumpRx role with administration

Oct 8, 2025, 4:05 PM EDT - 5 months ago

GoodRx Announces Date for Third Quarter 2025 Earnings Release and Conference Call

Oct 6, 2025, 9:15 AM EDT - 5 months ago

GoodRx Expands Affordable Access to Repatha® with Nearly 60% Savings

Oct 1, 2025, 5:17 PM EDT - 5 months ago

GoodRx Teams With Kroger on Prescription Savings

Oct 1, 2025, 9:10 AM EDT - 5 months ago

GoodRx expands tie-up with Kroger to offer branded drugs at discounted price

Oct 1, 2025, 9:00 AM EDT - 5 months ago

GoodRx Launches Brand Medication Savings Program at National Retail Pharmacy

Sep 16, 2025, 10:21 AM EDT - 6 months ago

GoodRx: Renewed Chance To Sign Up New Customers

Sep 2, 2025, 9:00 AM EDT - 6 months ago

GoodRx Saddles Up With “The Savings Wrangler,” a Bold New Brand Campaign to Tame the Wild West of Prescription Pricing

Aug 18, 2025, 3:47 PM EDT - 7 months ago

Is Novo Nordisk deal the much-needed catalyst for Goodrx stock?

NVO

Aug 18, 2025, 2:10 PM EDT - 7 months ago

GoodRx: After A 30% Surge On The Novo News, Is The Story Just Beginning?

Aug 18, 2025, 1:11 PM EDT - 7 months ago

Why is GDRX stock up 30% today? GoodRx strikes deal to sell Ozempic and Wegovy after Novo Nordisk's breakup with Hims

HIMS NVO

Aug 18, 2025, 10:29 AM EDT - 7 months ago

Novo Cuts Price of Ozempic in Half for Cash Buyers

NVO

Aug 18, 2025, 9:53 AM EDT - 7 months ago

GoodRx Stock Spikes 35% on Novo Nordisk Collaboration. They're Offering Ozempic for $499 a Month.

NVO

Aug 18, 2025, 9:05 AM EDT - 7 months ago

GoodRx Announces Collaboration with Novo Nordisk to Expand Access to Ozempic® and Wegovy® for $499-Per-Month

Aug 8, 2025, 1:24 PM EDT - 7 months ago

GoodRx Holdings, Inc. (GDRX) Q2 2025 Earnings Call Transcript

Aug 6, 2025, 4:05 PM EDT - 7 months ago

GoodRx Reports Second Quarter 2025 Results

Jul 28, 2025, 9:00 AM EDT - 8 months ago

GoodRx Appoints Amazon Pharmacy Veteran Laura Jensen as President of Pharma Solutions

Jul 9, 2025, 4:05 PM EDT - 8 months ago

GoodRx Announces Date for Second Quarter 2025 Earnings Release and Conference Call

Jul 8, 2025, 7:36 AM EDT - 8 months ago

GoodRx: A One Big Beautiful Bill Act Beneficiary

Jun 10, 2025, 9:00 AM EDT - 9 months ago

GoodRx Launches New Erectile Dysfunction Subscription Service to Simplify Access and Eliminate Treatment Barriers

Jun 9, 2025, 9:00 AM EDT - 9 months ago

GoodRx Launches Community Link to Offer Independent Pharmacies Cost-Plus Pricing

Jun 6, 2025, 3:59 AM EDT - 10 months ago

GoodRx: Stabilizing Revenue Amid Healthy Profit Gains

Jun 5, 2025, 9:00 AM EDT - 10 months ago

GoodRx Open Sources Lifecycle to Support Innovation in Software Development Velocity and Developer Productivity

May 22, 2025, 9:00 AM EDT - 10 months ago

GoodRx to Launch Direct Contracting for Independent Community Pharmacies

May 19, 2025, 2:14 PM EDT - 10 months ago

GoodRx Offers Value Proposition As Pharmacy Costs Shifts To Consumers: Analyst

May 8, 2025, 12:20 PM EDT - 11 months ago

GoodRx Holdings, Inc. (GDRX) Q1 2025 Earnings Call Transcript

May 7, 2025, 4:13 PM EDT - 11 months ago

GoodRx Reports First Quarter 2025 Results

Apr 9, 2025, 4:05 PM EDT - 1 year ago

GoodRx Announces Date for First Quarter 2025 Earnings Release and Conference Call

Hihosilveraway11 Mar. 16 at 3:42 AM

$GDRX can we get out of the 2s already!

0 · Reply

Yayomamon Mar. 15 at 6:27 AM

$GDRX okay everyone be honest what’s our price target for this year bc it’s not looking so great rn unfortunately

1 · Reply

WallStreetBuyDip Mar. 15 at 4:54 AM

0 · Reply

NowWeKnow Mar. 15 at 2:33 AM

$GDRX Orange 🍊 turd will kill all momentum

0 · Reply

JPC30 Mar. 14 at 6:25 PM

$GDRX will do great in time. current holdings 15,000 shares. aim to have around $30,000 if price continues to chop between here n lows

0 · Reply

Yayomamon Mar. 14 at 5:18 AM

$GDRX 5$ please god

0 · Reply

Plumbcrazy1017 Mar. 14 at 1:40 AM

$GDRX it’s going to go up

0 · Reply

PivotalSaints Mar. 13 at 9:59 PM

$BITF $GDRX $SOL.X $SPY Hilarious

0 · Reply

PivotalSaints Mar. 13 at 7:41 PM

$BITF $GDRX $SOL.X $SPY Now what? You’ve answered incorrectly every time so where do we go? Up

0 · Reply

fishinNbanjo Mar. 13 at 7:41 PM

$GDRX it's never going up

0 · Reply

Hihosilveraway11 Mar. 13 at 7:26 PM

$GDRX been stuck here for awhile now😡

0 · Reply

PivotalSaints Mar. 13 at 7:21 PM

$BITF $GDRX $SOL.X $SPY Even more hilarious

0 · Reply

PivotalSaints Mar. 13 at 7:17 PM

$BITF $GDRX $SOL.X $SPY Hilarious

0 · Reply

PivotalSaints Mar. 13 at 7:13 PM

$BITF $GDRX $SOL.X $SPY Them using Robots in real time against me still not rendering correctly $SPYD

0 · Reply

PivotalSaints Mar. 13 at 7:12 PM

$BITF $GDRX $SPY Yeah but where on a parabola? Whats the limit? $SOL.X So still incorrect

0 · Reply

PivotalSaints Mar. 13 at 6:46 PM

$GDRX $BITF Just a coincidence 😂 $SPY

0 · Reply

Hihosilveraway11 Mar. 13 at 1:49 PM

$GDRX come on Breakout! 🐂🐂🐂🐂🐂🐂🐂🐂🐂🐂🐂🐂🐂

0 · Reply

fishinNbanjo Mar. 13 at 1:35 PM

$GDRX literally never going up

0 · Reply

PivotalSaints Mar. 13 at 1:01 PM

$GDRX $HOOD $QNTM $SPY Is no one watching this break in real time with me? I’m unwinding this market like a threaded spool… 🧵 Your sorcery isn’t strong enough. Try harder.

2 · Reply

PivotalSaints Mar. 13 at 1:00 PM

$QNTM $GDRX $HOOD $SPY Terrible lie you’ve done on the populace

0 · Reply

PivotalSaints Mar. 13 at 12:58 PM

$GDRX $HOOD $SPY Suk it bish

0 · Reply

PivotalSaints Mar. 13 at 12:50 PM

$GDRX @ $HOOD 🫵 🖕🖕$SPY 50%vwap my 🥜

0 · Reply

Market Cap	760.33M
Revenue (ttm)	796.85M
Net Income (ttm)	30.44M
EPS (ttm)	N/A
PE Ratio	12.44
Forward PE	14.69
Profit Margin	3.82%
Debt to Equity Ratio	0.79

Volume	1,352,100
Avg Vol	3,415,438
Day's Range	N/A - N/A
Shares Out	339.43M
Stochastic %K	49%
Beta	1.52
Analysts	Sell
Price Target	$2.97